isomethyleugenol and Thrombocytopenia
isomethyleugenol has been researched along with Thrombocytopenia in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Baba, R; Hara, R; Hibino, R; Hirakawa, T; Igaki, S; Ito, M; Iwasaki, S; Iwatani, M; Kamada, H; Kamada, Y; Kimura, H; Matsuda, S; Matsumiya, K; Morimoto, S; Oki, H; Toyofuku, M; Tsuchida, K | 1 |
Akria, L; Arad, A; Aviv, A; Braester, A; Dally, N; Filanovsky, K; Gafter-Gvili, A; Gatt, ME; Hellmann, I; Herishanu, Y; Herzog-Tzarfati, K; Leiba, R; Merkel, D; Mittelman, M; Nagler, A; Nemets, A; Ofran, Y; Ronson, A; Rouvio, O; Silbershatz, I; Tadmor, T; Vidal, L; Yeganeh, S | 1 |
Other Studies
2 other study(ies) available for isomethyleugenol and Thrombocytopenia
Article | Year |
---|---|
T-448, a specific inhibitor of LSD1 enzyme activity, improves learning function without causing thrombocytopenia in mice.
Topics: Animals; Benzamides; Brain; Cells, Cultured; Enzyme Inhibitors; Histone Demethylases; Histones; Humans; Male; Maze Learning; Methylation; Mice; Neurons; Primary Cell Culture; Proto-Oncogene Proteins; Rats; Repressor Proteins; Thrombocytopenia | 2019 |
Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: a retrospective multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Chromosome Aberrations; Disease Susceptibility; Female; Humans; Incidence; Infections; Israel; Leukemia, Myeloid, Acute; Male; Methylation; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Retrospective Studies; Risk Factors; Severity of Illness Index; Thrombocytopenia | 2013 |